BERLIN () -German pharma company Bayer reported positive study ​results for its anticoagulant asundexian on Sunday,‌ two years after a research setback for the ‌promising blood thinner candidate. In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared ⁠with a placebo,‌ Bayer said.

When confronted with legitimate difficulties in handling our migration papers, it's fundamental to comprehend when and how a movement attorney

Exposure to freezing temperatures near Morocco’s border with Algeria killed nine African migrants, a tragedy that rights groups in the North African country called deeply concerning and a violation of the right to freedom of movement. The bodies of seven men and two women were found in Ras Asfour, a remote mountainous Moroccan area known for its plunging temperatures in winter, the Moroccan Association of Human Rights said Saturday in a statement. The rest were from various countries throughou